University of Miami
S

New Treatments for Steatotic Liver Disease (SLD): Are We There Yet?

By University of Miami FEATURING Stephen A. Harrison
By University of Miami FEATURING Stephen A. Harrison
10 views
April 12, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

18:46
Houston Methodist Hospital

MAFLD: What Is It?

Feat. D. Victor
27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

26:49
Diana Isaacs

Tirzepatide Updates

06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

36:34
Scripps Health

GLP-1 Hysteria

Feat. S. Harris
13:33
Dr. Sharmila Ghimire

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesi…

Feat. D. Ghimire
43:23
MedNews Week

Best Practices In Managing NAFLD / NASH

Feat. D. Bernstein
05:40
Susan Brian

An Introduction to Tirzepatide for Weightloss

49:21
McMaster University Department of Medicine

Semaglutide: Where Are We Now and Where Are We Going?

Feat. S. Boushahri, D. Lazzam, K. MacEachern
10:02
Susan Brian

Tirzepatide and Type 1 Diabetes

10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez
37:10
Diana Isaacs

Clinical Pearls & Updates on Incretins: The Diabetes Drugs Takin…

31:46
ACC 2024 Insights

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …

Feat. M. Costanzo